<DOC>
	<DOC>NCT03015090</DOC>
	<brief_summary>The aim of this study is to determine whether common CYP1A2 gene polymorphisms effect metabolism of theophylline in Han and Uygur Patients with chronic obstructive pulmonary disease patients.</brief_summary>
	<brief_title>Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Aged 1875 years,Weight 4080kg COPD patients, male or female; regularly visiting our hospital; taking a sustainedrelease preparation of theophylline continuously for at least 2 weeks Patients with renal or hepatic dysfunction; Patients with congestive heart failure; Patients with hypothyroidism or hyperthyroidism; Patients currently taking drugs likely to effect theophylline metabolism or who had taken such drugs in the preceding week; Patients with extreme obesity Patients with very severe Chronic Obstructive Pulmonary Disease(COPD)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>COPD</keyword>
	<keyword>CYP1A2</keyword>
	<keyword>Theophylline</keyword>
</DOC>